The result of immunohistochemistry showed that the expression of TRAF3IP2 was higher in NONO-TFE3 tRCC than in ccRCC (Fig. 1A). Here, TRAF3IP2 is linked to renal cell carcinoma associated with Xp11.2 translocations/TFE3 gene fusions.